Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2010
03/17/2010EP2161997A1 Tricyclic inhibitors of fatty acid amide hydrolase
03/17/2010EP2161996A1 Carboxamide heterocyclic cgrp receptor antagonists
03/17/2010EP2161995A1 A drug demonstrating anxiolytic effect based on hydrogenated pyrido (4, 3-b) indoles, its pharmacological compound and application method
03/17/2010EP1966191B1 Substituted pyrazinone derivatives as alpha2c-adrenoreceptor antagonists
03/17/2010EP1817300B1 Potentiators of glutamate receptors
03/17/2010EP1689742B1 Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity
03/17/2010EP1641423B1 Benzodiazepine cgrp receptor antagonists
03/17/2010EP1560813B1 Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
03/17/2010EP1513814B1 Novel piperidine compound
03/17/2010EP1315502B1 Method for treating erectile dysfunction and increasing libido in men
03/17/2010CN101675060A Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
03/17/2010CN101675049A Amimomethyl azaadamantane derivatives and use thereof as selective modulators of the alpha7- neuronal nicotinic acetylcholine receptor (nnrs)
03/17/2010CN101675046A therapeutic agents
03/17/2010CN101675045A Hetarylanilines as modulators for amyloid beta
03/17/2010CN101675040A Pyridine derivatives
03/17/2010CN101675035A Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments
03/17/2010CN101675032A Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands
03/17/2010CN101674831A Piperidine derivatives and methods of use thereof
03/17/2010CN101674830A Novel therapeutic uses of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine
03/17/2010CN101674829A Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of spinal cord traumas
03/17/2010CN101674826A Compounds, screens, and methods of treatment
03/17/2010CN101674819A Use of s1p receptor modulator
03/17/2010CN101671673A Mice tyrosine hydrozylase promoter and recombination expression vector thereof
03/17/2010CN101671554A Silica-coated fluorescent magnetic nanoparticle, preparation method and application
03/17/2010CN101671389A Erythrocyte generating characteristic-free erythropoietin with nervous protecting function and application thereof
03/17/2010CN101671388A Blood brain barrier penetrable erythropoietin (EPO) and application thereof
03/17/2010CN101671310A Compounds and compositions useful as cathepsin s inhibitors
03/17/2010CN101671260A Method for preparing O-desmethyl-venlafaxine
03/17/2010CN101671248A Long effective curcumin derivative and preparation method thereof
03/17/2010CN101670119A polynucleotide
03/17/2010CN101670111A Thioctic acid-glucan conjugate, preparation method and usage thereof
03/17/2010CN101670105A Humanized antibodies chelated with amylord beta peptide
03/17/2010CN101670083A Chinese medicinal composition for treating facial nerve paralysis
03/17/2010CN101670082A Liqueur-filled candy with Chinese medicinal health wine for treating migraine
03/17/2010CN101670077A Attenuated compatibility formula of minor Chinese thorowax root decoction
03/17/2010CN101670075A Traditional Chinese medicine composition for treating depression
03/17/2010CN101670054A Chinese medicinal material with multiple efficacies
03/17/2010CN101670038A Compound fleece-flower root extract capsule and preparation method and usage thereof
03/17/2010CN101670035A Chinese medicinal composition for treating cancerous pain and preparation method thereof
03/17/2010CN101670033A Ointment for curing protrusion of lumbar vertebral disc, sciatica, pain of neck, shoulder and legs, rheumatoid arthritis and hyperosteogeny
03/17/2010CN101670032A Substance obtained from sweet potato and application thereof
03/17/2010CN101670027A Compound fleece-flower root oral liquid, preparation method thereof and quality control method
03/17/2010CN101669994A Pharmaceutical composition for tranquilizing to relieve muscle spasm
03/17/2010CN101669992A Distinguishing method and measuring method of perilla leaf oil
03/17/2010CN101669977A Quality detection method of dogbane leaf capsule
03/17/2010CN101669960A Akebiasaponin D and application of composition thereof in preparation of medicaments for treating senile dementia
03/17/2010CN101669945A Joint synergy of ferulic acid and matrine alkaloid and medical application thereof
03/17/2010CN101669937A Composition of ginkgolide and ganglioside and preparation method thereof
03/17/2010CN101669933A Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
03/17/2010CN101669932A Application of long effective curcumin derivative in preparing anti-depression drug
03/17/2010CN101669928A Slow-release composition containing antidepressant
03/17/2010CN101669920A Strong anti-oxidation DHA microcapsule and preparation method thereof
03/17/2010CN101669663A Mulberry active juice beverage for sobering up and protecting liver and preparation method thereof
03/17/2010CN101669660A Traditional Chinese medicine fruit and vegetable juice drink for quitting smoking (sugar-free)
03/17/2010CN101669648A Dormitive heath care Chinese medicinal tea flavored egg and manufacturing method thereof
03/17/2010CN101669637A Application of cornflower-3-O-galactoside in preparing foods or medicaments for improving cognitive functions of old people
03/17/2010CN101669634A Method for preparing beverage capable of preventing and curing neurasthenic
03/17/2010CN101669549A Method for preparing milk tea capable of preventing and curing neurasthenic
03/17/2010CN100594027C Percutaneous medicine of strychnine, toxiferine, securinine and salt thereof
03/17/2010CN100594024C Permeability nose absorption type medicine for treating and preventing senile dementia, improving learning memory faculty and regulating blood brain barrier
03/16/2010US7678930 Process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid
03/16/2010US7678887 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade
03/16/2010US7678834 Substituted 4-aminocyclohexanol compounds
03/16/2010US7678814 Aroyl-piperidine derivatives
03/16/2010US7678812 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
03/16/2010US7678809 Useful in the treatment of chronic and acute pain; 1-[4-dibenzocycloheptyl-4-piperidinyl]-1,3-dihydro-2H-1,3-benzamidazol-2-one;
03/16/2010US7678799 Crystalline ziprasidone HCl and processes for preparation thereof
03/16/2010US7678793 Azolo triazines and pyrimidines
03/16/2010US7678788 (1,4-Diaza-bicyclo[3.2.2]non-4-yl)-5-(4-nitrophenyl)-furan-2-yl-methanone; nicotinic acetylcholine receptor inhibitors; nervous system disorders, neurodegeneration, inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances
03/16/2010US7678760 Inhibitors of Memapsin 2 and use thereof
03/16/2010US7678378 Compounds for intracellular delivery of therapeutic moieties to nerve cells
03/16/2010CA2510519C Condensed furan compounds
03/16/2010CA2492467C Injectable depot formulation comprising crystals of iloperidone
03/16/2010CA2423616C Chemokine mutants in the treatment of multiple sclerosis
03/16/2010CA2396965C Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
03/16/2010CA2390590C Adenosine receptor antagonists and methods of making and using the same
03/16/2010CA2386980C Benzodiazepine derivatives for use in acute or chronic neurological disorders
03/16/2010CA2372575C Bradykinin receptor antagonists
03/16/2010CA2336846C Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric g protein
03/11/2010WO2010028213A2 N-sulfonamido polycyclic pyrazolyl compounds
03/11/2010WO2010028207A2 Method of treatment of attention deficit/hyperactivity disorder (adhd)
03/11/2010WO2010028134A2 Treatment of neurological disorders using huperzine
03/11/2010WO2010028130A2 Antidepressant compounds
03/11/2010WO2010028033A1 Amides of diazabicyclooctanes and uses thereof
03/11/2010WO2010028011A1 Amides of diazabicyclononanes and uses thereof
03/11/2010WO2010027875A2 Compounds that modulate intracellular calcium
03/11/2010WO2010027770A1 Crystalline forms of sufentanil citrate
03/11/2010WO2010027500A1 Aminotriazolopyridines and their use as kinase inhibitors
03/11/2010WO2010027266A1 Means and methods for counteracting neurological disorders
03/11/2010WO2010027264A1 Hangover relief by compositions comprising oral rehydration solution
03/11/2010WO2010027097A1 Tri-substituted pyrimidine compounds and their use as pde10 inhibitors
03/11/2010WO2010027028A1 Agent for ameliorating impaired brain function
03/11/2010WO2010027014A1 Method for improving absorption of s-adenosyl-l-methionine, and composition having improved s-adenosyl-l-methionine absorption
03/11/2010WO2010027002A1 Ring-fused morpholine derivative having pi3k-inhibiting activity
03/11/2010WO2010026735A1 AMYLOID β AGGREGATION PROMOTION PEPTIDE AND APPLICATION THEREOF
03/11/2010WO2010026487A1 Therapeutic methods and compositions
03/11/2010WO2010026436A2 Pharmaceutical compounds
03/11/2010WO2010026435A1 Use of 3,11b-cis-dihydrobenazine in the treatment of dementia and associated cognitive deficit
03/11/2010WO2010026388A1 Isatin derivatives for use as in vivo imaging agents
03/11/2010WO2010026214A1 Pyrazolopyrimidines and their use for the treatment of cns disorders
1 ... 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 ... 1833